![Dawn P. Eringis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dawn P. Eringis
Corporate Officer/Principal en PolyMedix Pharmaceuticals, Inc. .
Cargos activos de Dawn P. Eringis
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PolyMedix Pharmaceuticals, Inc. | Corporate Officer/Principal | 01/01/2003 | - |
Historial de carrera de Dawn P. Eringis
Antiguos cargos conocidos de Dawn P. Eringis.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Locus Pharmaceuticals, Inc.
![]() Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Corporate Officer/Principal | 01/01/2000 | 01/01/2002 |
POLYMEDIX, INC. | Corporate Officer/Principal | 01/11/2005 | - |
Formación de Dawn P. Eringis.
University of Pennsylvania | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 5 |
Operativa
Corporate Officer/Principal | 3 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
PolyMedix, Inc.
![]() PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology PolyMedix, Inc. engaged in developing first-in-class, small-molecule defensin-mimetics for the treatment of serious acute care conditions. The company was founded in 2002 and was headquartered in Radnor, PA. | Health Technology |
PolyMedix Pharmaceuticals, Inc. | |
Locus Pharmaceuticals, Inc.
![]() Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Health Technology |
- Bolsa de valores
- Insiders
- Dawn P. Eringis
- Experiencia